Recombinant erythropoietin products are utilized to treat anemia conditions caused due to renal diseases, cancer, HIV/AIDS, and other chronic illnesses.
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |